查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585822

乳房病變定位市場：按類型、應用和最終用途分類 - 全球預測 2025-2030

Breast Lesion Localization Methods Market by Type (Electromagnetic Localization, Magnetic Localization, Radioisotope Localization), Usage (Lumpectomy, Mastectomy, Sentinel Lymph Node Identification), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年乳房病變定位市場價值為12億美元，預計2024年將達到13.9億美元，複合年成長率為15.74%，預計2030年將達到33.6億美元。

乳房病變定位市場圍繞著用於準確識別和標記乳房組織病變的技術和技術，這對於精確的手術干預和改善患者的治療效果至關重要。對此類技術的主要需求是由乳癌盛行率的不斷增加所驅動的，這需要提高診斷和手術的準確性以提高存活率和患者護理。乳房病灶定位廣泛應用於醫院、診所和診斷中心，在乳房保留手術和術前治療中發揮重要作用，使患者和醫療保健人員受益。由於影像導引立體定位技術和無線方法等技術進步滿足了對有效和微創手術日益成長的需求，該市場顯示出巨大的成長潛力。關鍵的成長要素包括早期癌症檢測意識的提高、醫療保健基礎設施的改善以及對癌症研究的大量投資。然而，監管障礙、先進技術的高成本以及新興市場進入有限等挑戰可能會阻礙市場開拓。

主要市場統計
基準年[2023] 12億美元
預測年份 [2024] 13.9億美元
預測年份 [2030] 33.6億美元
複合年成長率（%） 15.74%

現代商業機會存在於新定位技術的研究和開發中，例如 RFID（無線射頻識別）標籤和磁性種子定位。企業應注重策略聯盟和夥伴關係關係，以擴大技術力和市場覆蓋範圍。對微創手術的重視是技術創新的一個有前途的領域，與人工智慧和機器學習技術的整合可以進一步徹底改變早期檢測和準確性。市場競爭非常激烈，但產品供應的創新和擴大地理分佈（尤其是在新興市場）將是有益的。洞察表明，持續創新、響應監管變化以及提高成本效率對於成功至關重要。隨著以患者為中心的方法變得越來越普遍，對旨在實現永續成長的市場參與者而言，能夠與現有診斷系統無縫整合的改進的本地化技術的需求仍然至關重要。

市場動態：快速發展的乳房病變定位市場的關鍵市場洞察

供需的動態交互作用正在改變乳房病變定位市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 乳癌發生率上升，乳癌手術數量增加
    • 提高乳癌早期檢測意識
    • 政府在乳癌研究上的支出
  • 市場限制因素
    • 監理核准程序的不確定性
  • 市場機會
    • 更多採用技術先進的乳房定位方法
    • 乳房病變無線定位的出現
  • 市場挑戰
    • 對腫瘤科醫師短缺的擔憂

波特五力：駕馭乳房病變定位市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解乳房病變定位市場的外部影響

外部宏觀環境因素在塑造乳房病變定位方法市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解乳房病變定位市場的競爭格局

對乳房病變定位方法市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣乳房病變定位市場供應商績效評估

FPNV定位矩陣是評估乳房病變定位市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與推薦的乳房病變定位方法市場成功之路

對於旨在加強其在全球市場的影響力的公司來說，對乳房病變定位方法市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 乳癌發生率和乳癌手術數量增加
      • 意識提升
      • 政府在乳癌研究上的支出
    • 抑制因素
      • 監理核准流程的不確定性
    • 機會
      • 更多採用技術先進的本地化程序
      • 乳腺病灶無線定位技術的出現
    • 任務
      • 對腫瘤科醫師短缺的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章乳房病變定位市場：依類型

  • 電磁定位
  • 磁定位
  • 放射性同位素定位
  • 電線位置

第7章乳房病變定位方法市場（依應用）

  • 切除術
  • 切除術
  • 前哨淋巴結的識別
  • 腫瘤鑑定

第8章乳房病變定位市場：依最終用途

  • 門診治療中心
  • 影像診斷中心
  • 醫院

第9章北美及南美乳房病變定位市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區乳房病變定位市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲乳房病灶定位市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company
  • BIOPSYBELL SRL
  • CP Medical
  • Cianna Medical, Inc.
  • Cook Group
  • Endomagnetics Limited
  • Hologic, Inc.
  • ILUMARK GmbH
  • Intramedical Imaging
  • Intramedical Imaging, LLC
  • IsoAid, LLC
  • IZI Medical Products by Halma PLC
  • Laurane Medical LLC
  • Merit Medical Systems, Inc.
  • Mermaid Medical
  • Molli Surgical Inc.
  • Ranfac Corp.
  • Sirius Medical System BV
  • SOMATEX Medical Technologies GmbH by Hologic
  • Sterylab Srl
  • Stryker Corporation
  • Wright Medical Group NV
Product Code: MRR-374DB5A06AFC

The Breast Lesion Localization Methods Market was valued at USD 1.20 billion in 2023, expected to reach USD 1.39 billion in 2024, and is projected to grow at a CAGR of 15.74%, to USD 3.36 billion by 2030.

The Breast Lesion Localization Methods market revolves around the techniques and technologies used to accurately identify and mark lesions in breast tissue, crucial for precise surgical interventions and better patient outcomes. The primary necessity for these methods is driven by the increasing prevalence of breast cancer, which demands enhanced diagnostic and surgical precision to improve survival rates and patient care. Widely applied in hospitals, clinics, and diagnostic centers, breast lesion localization plays a critical role in breast-conserving surgeries and pre-operative procedures, benefiting both patients and healthcare providers. The market demonstrates substantial growth potential due to technological advancements such as image-guided localization and wireless methods, addressing the rising demand for effective and minimally invasive techniques. Key growth influencers include the increasing awareness of early cancer detection, improved healthcare infrastructure, and significant funding in cancer research. However, challenges such as regulatory hurdles, high costs of advanced technology, and limited accessibility in developing regions can hinder market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.20 billion
Estimated Year [2024] USD 1.39 billion
Forecast Year [2030] USD 3.36 billion
CAGR (%) 15.74%

Latest opportunities exist in the R&D of novel localization techniques like radiofrequency identification (RFID) tags and magnetic seed localization, which promise enhanced accuracy and patient comfort. Companies should focus on strategic collaborations and partnerships to expand their technological capabilities and market reach. The emphasis on minimally invasive procedures presents a promising area for innovation, while integration with AI and machine learning technologies may further revolutionize early detection and precision. Although the market is highly competitive, innovations in product offerings and expanding geographical presence, especially in emerging markets, could be beneficial. Insights show that continuous innovation, keeping pace with regulatory changes, and enhancing cost-efficiency will be vital for success. As patient-centric approaches gain traction, the demand for improved localization technologies that provide seamless integration with existing diagnostic systems remains pivotal for market players aiming towards sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Breast Lesion Localization Methods Market

The Breast Lesion Localization Methods Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of breast cancer and increasing number of breast cancer surgeries
    • Increasing awareness on the early detection of breast cancer
    • Government spending on breast cancer research
  • Market Restraints
    • Uncertainty in regulatory approval procedures
  • Market Opportunities
    • Increasing adoption of technologically advanced localization procedures
    • Emergence of wireless localization of breast lesion
  • Market Challenges
    • Concerns regarding the shortage of oncologists

Porter's Five Forces: A Strategic Tool for Navigating the Breast Lesion Localization Methods Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Breast Lesion Localization Methods Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Breast Lesion Localization Methods Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Breast Lesion Localization Methods Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Breast Lesion Localization Methods Market

A detailed market share analysis in the Breast Lesion Localization Methods Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Breast Lesion Localization Methods Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Breast Lesion Localization Methods Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Breast Lesion Localization Methods Market

A strategic analysis of the Breast Lesion Localization Methods Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Breast Lesion Localization Methods Market, highlighting leading vendors and their innovative profiles. These include Argon Medical Devices, Inc., Becton, Dickinson and Company, BIOPSYBELL S.R.L., C.P. Medical, Cianna Medical, Inc., Cook Group, Endomagnetics Limited, Hologic, Inc., ILUMARK GmbH, Intramedical Imaging, Intramedical Imaging, LLC, IsoAid, LLC, IZI Medical Products by Halma PLC, Laurane Medical LLC, Merit Medical Systems, Inc., Mermaid Medical, Molli Surgical Inc., Ranfac Corp., Sirius Medical System B.V., SOMATEX Medical Technologies GmbH by Hologic, Sterylab S.r.l., Stryker Corporation, and Wright Medical Group N.V..

Market Segmentation & Coverage

This research report categorizes the Breast Lesion Localization Methods Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Electromagnetic Localization, Magnetic Localization, Radioisotope Localization, and Wire Localization.
  • Based on Usage, market is studied across Lumpectomy, Mastectomy, Sentinel Lymph Node Identification, and Tumor Identification.
  • Based on End-Use, market is studied across Ambulatory Care Centers, Diagnostic Imaging Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of breast cancer and increasing number of breast cancer surgeries
      • 5.1.1.2. Increasing awareness on the early detection of breast cancer
      • 5.1.1.3. Government spending on breast cancer research
    • 5.1.2. Restraints
      • 5.1.2.1. Uncertainty in regulatory approval procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing adoption of technologically advanced localization procedures
      • 5.1.3.2. Emergence of wireless localization of breast lesion
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding the shortage of oncologists
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Breast Lesion Localization Methods Market, by Type

  • 6.1. Introduction
  • 6.2. Electromagnetic Localization
  • 6.3. Magnetic Localization
  • 6.4. Radioisotope Localization
  • 6.5. Wire Localization

7. Breast Lesion Localization Methods Market, by Usage

  • 7.1. Introduction
  • 7.2. Lumpectomy
  • 7.3. Mastectomy
  • 7.4. Sentinel Lymph Node Identification
  • 7.5. Tumor Identification

8. Breast Lesion Localization Methods Market, by End-Use

  • 8.1. Introduction
  • 8.2. Ambulatory Care Centers
  • 8.3. Diagnostic Imaging Centers
  • 8.4. Hospitals

9. Americas Breast Lesion Localization Methods Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Breast Lesion Localization Methods Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Breast Lesion Localization Methods Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Argon Medical Devices, Inc.
  • 2. Becton, Dickinson and Company
  • 3. BIOPSYBELL S.R.L.
  • 4. C.P. Medical
  • 5. Cianna Medical, Inc.
  • 6. Cook Group
  • 7. Endomagnetics Limited
  • 8. Hologic, Inc.
  • 9. ILUMARK GmbH
  • 10. Intramedical Imaging
  • 11. Intramedical Imaging, LLC
  • 12. IsoAid, LLC
  • 13. IZI Medical Products by Halma PLC
  • 14. Laurane Medical LLC
  • 15. Merit Medical Systems, Inc.
  • 16. Mermaid Medical
  • 17. Molli Surgical Inc.
  • 18. Ranfac Corp.
  • 19. Sirius Medical System B.V.
  • 20. SOMATEX Medical Technologies GmbH by Hologic
  • 21. Sterylab S.r.l.
  • 22. Stryker Corporation
  • 23. Wright Medical Group N.V.

LIST OF FIGURES

  • FIGURE 1. BREAST LESION LOCALIZATION METHODS MARKET RESEARCH PROCESS
  • FIGURE 2. BREAST LESION LOCALIZATION METHODS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BREAST LESION LOCALIZATION METHODS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BREAST LESION LOCALIZATION METHODS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BREAST LESION LOCALIZATION METHODS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BREAST LESION LOCALIZATION METHODS MARKET DYNAMICS
  • TABLE 7. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY ELECTROMAGNETIC LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MAGNETIC LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY RADIOISOTOPE LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY WIRE LOCALIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY LUMPECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY MASTECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY SENTINEL LYMPH NODE IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TUMOR IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM BREAST LESION LOCALIZATION METHODS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. BREAST LESION LOCALIZATION METHODS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. BREAST LESION LOCALIZATION METHODS MARKET, FPNV POSITIONING MATRIX, 2023